The real tragedy on Married At First Sight that Australia should be talking about....
8 March 2017
Australia, we need to talk. This week’s dramatic episodes of Married At First Sight have highlighted a tragedy which is ripping Australian families apart. Yet no one is talking about it.
Whilst public discussion focuses on Cheryl and Andrew’s tumultuous relationship, we should be talking about something far more sinister. At their ‘relationship boot camp’ Cheryl was clearly shown sporting badly sunburnt shoulders and back. Her skin was bright red, it looked painful, and I’m sure viewers noticed. Yet no-one batted an eyelid.
Well, I am calling it. The national discussion about young Australians and melanoma needs to start, and it needs to start now. Our young adults are dying from melanoma. Sons, daughters, brothers, sisters, young parents – lost to melanoma, Australia’s national cancer, at the prime of their lives.
Melanoma is the most common cancer affecting 15-39 year-old Australians. It kills more 20-39 year olds than any other single cancer. One Australian dies from melanoma every six hours. Yet, it is largely preventable.
Intense, intermittent UV exposure leading to sunburn radically increases your chance of developing potentially deadly melanoma. So why are we sitting back and admiring a young woman with a bad case of sunburn on an Australian reality television show, and not discussing it?
Time to get with the program. The famous line, “I love a sunburnt country”, was written way back in 1908. Sun tanning products became sunscreen products back in the 80s, for a reason. Television shows moved on from showing contestants driving without seatbelts, or smoking, to send the right public health and safety messages. It is time to place the same importance on sending life-saving sun safety messages to impressionable young Australians. We banned sunbeds (another driver for melanoma), time to ban sunburn.
Cheryl’s sunburn was front and centre during Melanoma March, our annual awareness month, when I meet a truly heart-wrenching number of partners and parents who have lost their loved ones to melanoma at 24, 32 or 38. Come on Australia, who is ready to join the conversation and help us end melanoma?
Carole Renouf
CEO, Melanoma Institute Australia
For more information, please contact: Jennifer Durante |Melanoma Institute Australia | 0412 798 990 | jennifer.durante@melanoma.org.au
Melanoma Patients Australia Symposium - Webinar 2
Join us at the 2nd Melanoma Patients Australia webinar 'Psychological Health & Wellbeing'.
City2Surf 2020
You're invited to be a C2S charity superstar, and together we can run over melanoma!
City2Surf 2020
Join in the fun of the virtual event, and together we can run over melanoma!
Top melanoma experts from MIA
Melanoma Institute Australia features prominently in the latest ‘Expertise in Melanoma’ world rankings, released by Expertscape.
Melanoma Supportive Care Needs research study.
Participate in our online survey and help us understand the support needs of melanoma patients and carers.
New data reveals long-term benefit of adjuvant therapy for Stage III melanoma.
New online melanoma risk calculators critical to saving lives
Clinicians and their patients now have access to three online risk calculators developed by researchers at Melanoma Institute Australia.
Professor Richard Scolyer receives University of Sydney Alumni Award.
MIA's Co-Medical Director Professor Richard Scolyer has received The University of Sydney Alumni Award for International Achievement.
Uniting together despite the distance
More than 120 MIA clinicians, researchers and staff came together online to share research highlights.
Professor Richard Scolyer recognised in The Pathologist's 2020 Power List.
For the 2nd consecutive year, MIA's Co-Medical Director Professor Richard Scolyer has been selected in the top 100 best, brightest, and most powerful advocates of pathology by The Pathologist.
Important Update: Masks required at Poche Centre
As of Monday 27th July all patients and carers/family members coming into The Poche Centre will be required to bring their own mask.
A Critical Nexus:The Clinician and the Researcher.
In a recent issue of Cancer Cell journal, Prof Georgina Long AO and Prof Richard Scolyer discuss the challenge of bringing together clinical work and scientific research to underpin successful cancer research.
New online calculator launched to determine risk of spread of melanoma
Clinicians around the world now have access to a new online calculator that predicts the risk that a patient’s primary melanoma has spread to nearby lymph nodes.
Queen's Birthday Honour for Professor Georgina Long
Professor Long has been appointed as an Officer (AO) of the Order of Australia (General Division) for distinguished service to medicine, particularly, to melanoma clinical and translational research, and to professional medical societies.
Danny's inspiring survival story
“I had a complete response within about six months. All of my tumours disappeared."
MIA in the spotlight at ASCO virtual conference
‘We are extremely proud of our ongoing contribution to the global effort to save lives from melanoma, with Dr Silva’s prestigious award proof that we continue to lead the way,'
Professor Richard Scolyer achieves h-index of 100
MIA's Co-Medical Director, Professor Richard Scolyer, has achieved a Google Scholar h-index of 100.
See how we connected at Melanoma March Virtual 2020
We know what Melanoma March means to our community, so when we had to cancel our physical events, we created Melanoma March Virtual so that everyone across Australia could still connect to honour loved ones and support each other.
Melanoma meets its match.
A must-read personal account by Garry Maddox in The Sydney Morning Herald of how immunotherapy is revolutionising melanoma treatment.
Next Steps for National Screening Program for Melanoma
On Friday, a publication that lays out the steps needed to find out if a systematic screening program for melanoma would benefit all Australians was published in the Australia & New Zealand Journal of Public Health.